NEOCUTIS® RECEIVES ITS 15th InStyle ”BEST BEAUTY BUY” AWARD. Lumière® and Lumière Riche Recognized by InStyle as Best Eye Treatments
Merz Aesthetics, a division of Merz North America (US affiliate of the global Merz Pharma Group), announced today that NEO CUTIS® Lumière and Lumière Riche were named InStyle 2016 “Best Beauty Buys” award winners for Best Eye Treatment and Best Eye Treatment for Dry Skin, respectively. Each year the publication polls the industry’s top experts to identify their must-have beauty products. This year’s winners are featured in the May 2016 issue of InStyle .
“It is an honor that InStyle continues to recognize our breakthrough formulas as Best Beauty Buys,” said Mark Lemko, Vice President and Head, Merz Aesthetics Skincare Division. “This is especially important to us because these products are relied upon by physicians to address common skincare concerns such as the signs of aging, oxidative stress and discoloration.”
This year’s InStyle award marks the 15th time that NEO CUTIS has been awarded the Best Beauty Buy title since 2009. Of those 15 award wins, Lumière has been honored as an InStyle Best Beauty Buy eight years in a row.
NEO CUTIS products are available for purchase exclusively through medical practices and skincare providers. For additional information, or to find an authorized NEO CUTIS Skincare provider near you, please visit www.NEO CUTIS.com
About Merz Aesthetics Skincare
Merz Aesthetics Skincare is a division of Merz North America, a specialty healthcare company dedicated to delivering a better total experience in aesthetics, dermatology and neurosciences. Merz Aesthetics Skincare brings together the precision of Swiss technology and cellular research for scientifically advanced breakthroughs in anti-aging and post-procedure skincare. Merz Aesthetics Skincare offers a full line of products designed to help diminish the visible signs of skin aging and address key skincare concerns, available exclusively through medical practices and skincare providers. To learn more about Merz Aesthetics and their Skincare offerings, please visit www.merzusa.com/aesthetics-otc.
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at www.merz.com.
05.03.2016 [ 0 KB ]
Merz North America